CA2128331A1 - Methods for using histamine derivatives as immunomodulators and in immunotherapeutics - Google Patents
Methods for using histamine derivatives as immunomodulators and in immunotherapeuticsInfo
- Publication number
- CA2128331A1 CA2128331A1 CA002128331A CA2128331A CA2128331A1 CA 2128331 A1 CA2128331 A1 CA 2128331A1 CA 002128331 A CA002128331 A CA 002128331A CA 2128331 A CA2128331 A CA 2128331A CA 2128331 A1 CA2128331 A1 CA 2128331A1
- Authority
- CA
- Canada
- Prior art keywords
- histamine
- chain
- substituted
- protein allergen
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82322992A | 1992-01-21 | 1992-01-21 | |
US07/823,229 | 1992-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2128331A1 true CA2128331A1 (en) | 1993-07-22 |
Family
ID=25238155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002128331A Abandoned CA2128331A1 (en) | 1992-01-21 | 1993-01-19 | Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0621780A1 (ja) |
JP (1) | JPH07503239A (ja) |
CN (1) | CN1078153A (ja) |
AU (1) | AU3591793A (ja) |
CA (1) | CA2128331A1 (ja) |
MX (1) | MX9300294A (ja) |
WO (1) | WO1993013772A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004075845A2 (en) * | 2003-02-24 | 2004-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
RS51840B (en) | 2005-09-01 | 2012-02-29 | Celgene Corporation | IMMUNOLOGICAL APPLICATIONS OF IMMUNOMODULATORY UNITS FOR VACCINE AND FOR INFECTIOUS DISEASE THERAPY |
JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
EP3564671B1 (en) | 2013-08-23 | 2021-09-29 | Regeneron Pharmaceuticals, Inc. | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) |
US11352417B2 (en) | 2016-12-22 | 2022-06-07 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
WO2018138607A1 (en) * | 2017-01-24 | 2018-08-02 | Nestec Sa | Compositions comprising anti-fel d1 antibodies and methods for reducing at least one symptom of human allergy to cats |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996221A (en) * | 1987-01-13 | 1991-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives as immune modulators |
-
1993
- 1993-01-19 CA CA002128331A patent/CA2128331A1/en not_active Abandoned
- 1993-01-19 AU AU35917/93A patent/AU3591793A/en not_active Abandoned
- 1993-01-19 EP EP93904617A patent/EP0621780A1/en not_active Withdrawn
- 1993-01-19 WO PCT/US1993/000664 patent/WO1993013772A1/en not_active Application Discontinuation
- 1993-01-19 JP JP5512737A patent/JPH07503239A/ja active Pending
- 1993-01-21 CN CN93102512A patent/CN1078153A/zh active Pending
- 1993-01-21 MX MX9300294A patent/MX9300294A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU3591793A (en) | 1993-08-03 |
CN1078153A (zh) | 1993-11-10 |
WO1993013772A1 (en) | 1993-07-22 |
JPH07503239A (ja) | 1995-04-06 |
EP0621780A1 (en) | 1994-11-02 |
MX9300294A (es) | 1994-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4447657B2 (ja) | 免疫寛容誘導剤 | |
RU2236257C1 (ru) | Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами | |
ES2205231T3 (es) | Procedimiento de tratamiento de la hipersensibilidad de tipo i que utilizan monofosforil lipido a. | |
JPH02501066A (ja) | IgE非関与型疾病の治療方法および治療用ペプチド | |
Konturek et al. | Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophoradin. Role of endogenous prostaglandins | |
Bartfeld et al. | Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor. | |
US5556872A (en) | Histamine derivatives useful as immunomodulators | |
US6699973B1 (en) | Antibodies to peptides that target GIT receptors and related methods | |
CA2128331A1 (en) | Methods for using histamine derivatives as immunomodulators and in immunotherapeutics | |
JPH03151400A (ja) | 化学修飾されたアレルゲン類およびそれらの調製方法 | |
Ahlstedt et al. | Specific antibody responses in rats and mice after daily immunization without adjuvant | |
Cara et al. | Immunological induction of flavour aversion in mice. II. Passive/adoptive transfer and pharmacological inhibition | |
Fujimaki et al. | Adjuvant effects of aluminum silicate on IgE and IgG1 antibody production in mice | |
Weinbaum et al. | Comparison of cross-reactivities between albumins of various species at the level of antibody and helper T cells—studies in mice | |
US4702907A (en) | Process for inducing selective immunosuppression of antibodies | |
Mitchell et al. | Lung granulomatous hypersensitivity to eggs of Schistosoma japonicum in mice analysed by a radioisotopic assay and effects of hybridoma (idiotype) sensitization | |
Peri et al. | Circulating antitoxin in rabbits after ingestion of diphtheria toxoid | |
Kemeny et al. | Immune response to bee venom: II. Quantitation of the absolute amounts of IgE and IgG antibodies by saturation analysis | |
Galle et al. | Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation | |
WO1993014754A1 (en) | Histamine derivatives and methods for their use as immunomodulators | |
JP2002249442A (ja) | アレルギー減感作治療薬 | |
RU2182492C1 (ru) | Лекарственное средство для лечения наркотической зависимости | |
RU2548802C1 (ru) | Иммуноген для лечения и профилактики зависимости от опиатов | |
Gamaleya et al. | Induction of antibodies to morphine during chronic morphine treatment in rodents and opiate addicts | |
Wheeler et al. | Adjuvant properties of hydrophobic derivatives prepared from L-tyrosine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |